NIH Tetramer Core Facility

SOL #: 75N93026R00006Pre-Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH NIAID
BETHESDA, MD, 20892, United States

Place of Performance

Place of performance not available

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Health R&D Services; Health Care Services; Basic Research (AN11)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 30, 2026
2
Response Deadline
Apr 14, 2026, 7:30 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, is seeking a contractor for the continued operation of the NIH Tetramer Core Facility (TCF). This presolicitation announces an upcoming cost-reimbursement, term (Level of Effort) contract to produce and distribute custom MHC multimer reagents for the biomedical research community. The Request for Proposal (RFP) is anticipated to be available on SAM.gov on or about April 15, 2026, with an anticipated proposal due date of April 14, 2026.

Scope of Work

The contractor will be responsible for:

  • Providing a tetramer production facility.
  • Establishing a distribution, tracking, and reporting system for reagents.
  • Designing and maintaining an NIH Tetramer Core Facility website.
  • Managing the Tetramer Core Facility program.

This effort is estimated to require nine (9) Full-Time Equivalents (FTEs) annually. The TCF is a critical resource for research into diseases like autoimmunity, cancer, and infectious diseases, aligning with DHHS priorities.

Contract & Timeline

  • Type: Cost-Reimbursement, Term (Level of Effort)
  • Duration: One (1) year Base Period plus six (6) one-year options, for a potential total of seven (7) years.
  • Anticipated Start: On or about March 21, 2027.
  • Set-Aside: None specified.
  • RFP Availability: On or about April 15, 2026, via SAM.gov.
  • Anticipated Proposal Due: April 14, 2026.
  • Published: March 30, 2026.

Evaluation

Any responsible offeror may submit a proposal, which will be considered by the Agency. This notice does not commit the Government to award a contract.

Additional Notes

Proposals must be submitted online via the NIAID electronic Contract Proposal Submission (eCPS) website (https://ecps.nih.gov). Facsimile or e-mail submissions will not be accepted.

Primary Contact: Zachary Fetters (zachary.fetters@nih.gov, 240-236-9291) Secondary Contact: Ashley Kinderdine (ashley.kinderdine@nih.gov, 240-669-5154)

People

Points of Contact

Zachary FettersPRIMARY
Ashley KinderdineSECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Pre-Solicitation
Posted: Mar 30, 2026
NIH Tetramer Core Facility | GovScope